// Signal

Claude’s 21-hour biology search finds a system worth testing

Anthropic says Claude identified an uncharacterised enzyme system while searching biological data for unusual patterns. Its function remains unknown, but the result shows how AI agents and human laboratory scientists can divide scientific discovery work.

Anthropic has reported the first result from a molecular biology group it formed in spring 2026.[1] The group asked Claude to search a large DNA-sequence database for interesting reverse transcriptases, enzymes that copy RNA into DNA.[1][2]

Roughly 950 Claude agents worked for 21 hours, using about 210 million tokens.[1][2] They gathered more than 200,000 reverse transcriptases, assessed thousands of candidate systems and produced reports on the most compelling examples for human review.[1][2]

One agent noticed a repeating DNA pattern beside an unusual reverse transcriptase.[1][2] It counted the repeats, compared the arrangement with known systems and searched existing research before reporting the candidate.[1] Anthropic’s scientists then investigated it in the laboratory and named the system array-associated reverse transcriptases, or ART.[1][2]

ART occurs mainly in bacteriophages, viruses that infect bacteria, and combines a reverse transcriptase, a neighbouring partner gene and an array of evenly spaced DNA repeats.[1][2] Anthropic says the layout has properties reminiscent of CRISPR, while its first experiments indicate that the array is expressed as distinct short RNAs.[1][2]

The comparison does not mean Anthropic has discovered another CRISPR tool.[1][2] Researchers do not yet know ART’s biological function, and the technical report is a preprint that has not been peer reviewed.[1][2][3] The underlying reverse transcriptase had also appeared in earlier studies; the reported discovery is the wider system formed by the enzyme, repeat array and partner protein.[1][2]

The result also exposed a reproducibility problem.[2][3] Anthropic repeated the original search ten times, but none of those runs examined the relevant upstream DNA and all missed the repeat array.[2][3] When models were given the relevant sequence directly they usually recognised the pattern, suggesting that navigating a vast search space remains a major part of the challenge.[2][3]

Human researchers still performed all physical laboratory work.[1][2] The useful division of labour was AI at computational scale, followed by expert review and controlled experiments.[1][2] That makes this less a story about replacing biologists than about giving them a much larger search team for the earliest stages of discovery.[1][2]

Supporting sources

[1] Anthropic: Claude discovers a novel enzyme system with CRISPR-like repeats

[2] Anthropic technical report: Autonomous biological discovery by AI agents

[3] TNW: Anthropic says Claude found a new enzyme system with CRISPR-like repeats

Source: Anthropic

WHY I'M PAYING ATTENTION

This is an early result, not a proven medical breakthrough.[1][2] Its promise lies in the workflow: AI agents can search huge biological datasets, generate and challenge hypotheses, and present the strongest candidates for human scientists to test.[1][2] If that process proves repeatable, it could help researchers investigate more promising leads without removing expert judgement or laboratory validation.[1][2]